All News

2019

June

Media Release / Jun 14, 2019

New Sandoz biosimilar adalimumab data confirms switching from reference biologic has no impact on safety or efficacy

Read More

May

Media Release / May 15, 2019

Sandoz announces plan to improve competitiveness and realign the organization, to drive ongoing Transformation and support future growth

Read More
Media Release / May 09, 2019

Sandoz demonstrates strategic focus on China, with first-of-a-kind generic approval under Quality Consistency Evaluation system

Read More

April

Media Release / Apr 30, 2019

Sandoz enters agreement for proposed trastuzumab biosimilar, currently in Phase III development, to treat selected HER2-positive cancer tumors

Read More
Media Release / Apr 24, 2019

Novartis starts 2019 with strong sales and double digit core[1] operating income growth, Mayzent launch and Alcon spin-off; profit guidance upgraded

Read More
Media Release / Apr 11, 2019

Sandoz drives differentiated portfolio with deal to commercialize new treatment for Opioid-Induced Constipation in key European countries

Read More
Media Release / Apr 02, 2019

Sandoz resubmits biosimilar pegfilgrastim application to US FDA

Read More

March

Media Release / Mar 14, 2019

Novartis announces change in Sandoz leadership

Read More
Media Release / Mar 10, 2019

Three winners of 2019 Sandoz Healthcare Access Challenge (HACk) are announced at SXSW

Read More

January

Media Release / Jan 31, 2019

Sandoz certified Global Top Employer 2019

Read More

Pages